A new drug administered orally shows significantly lower plasma concentrations than expected despite complete absorption from the gut. Which process explains why this 'first-pass' effect dominates the bioavailability?

💡 Explanation

The first-pass effect describes extensive drug metabolism in the liver before systemic circulation. This leads to lower bioavailability because the liver metabolizes a significant fraction of the drug before it reaches its target, therefore, hepatic metabolism causes reduced plasma concentrations, rather than renal excretion or protein binding.

• A patient with a known peanut allergy experiences sudden respiratory distress after accidentally ingesting peanut oil. Which mechanism explains this acute allergic reaction?
• Why does chronic sun exposure accelerate skin aging regarding elastin function?
• If a patient with chronic anemia also develops a severe lung infection causing localized acidosis in the pulmonary capillaries, which consequence follows regarding hemoglobin's oxygen affinity?
• An elderly patient with peripheral neuropathy struggles to maintain balance on uneven ground. Which mechanism primarily underlies this instability?
• Why does blood pressure in the aorta drop during the diastole phase of the cardiac cycle?
• Following meniscus removal with knee osteoarthritis, what action accelerates osteophyte formation?